Drug
Merck Glucophage High Dose
Merck Glucophage High Dose: highest development phase Phase 1, developed by Boehringer Ingelheim. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Boehringer Ingelheim
Trials
| Drug | Phase | Indication |
|---|---|---|
| Merck Glucophage® high dose NCT02183571 | Phase 1 | Healthy |
Latest
No recent events.
Follow Merck Glucophage High Dose on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.